Quiet on the insider front: nobody at Journey Medical Corp bought or sold DERM shares in open-market trades this past year.
Big money check: 71 institutions held DERM as of Q2 2026, and funds were split between buying and selling. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 5, 2025 | Maraoui Claude | CEO | Sell | 4,834 | $6.84 | $33K | SEC |
| May 5, 2025 | Benesch Joseph | CFO | Sell | 2,409 | $6.84 | $16K | SEC |
| May 5, 2025 | Alloush Ramsey | COO | Sell | 2,857 | $6.84 | $20K | SEC |
| Mar 11, 2025 | Maraoui Claude | CEO | Sell | 49,271 | $5.01 | $247K | SEC |
| Mar 10, 2025 | Maraoui Claude | CEO | Sell | 14,905 | $5.01 | $75K | SEC |
| Mar 10, 2025 | Maraoui Claude | CEO | Sell | 25,551 | $5.04 | $129K | SEC |
| Mar 5, 2025 | Maraoui Claude | CEO | Sell | 23,508 | $5.19 | $122K | SEC |
| Mar 5, 2025 | Maraoui Claude | CEO | Sell | 18,147 | $5.13 | $93K | SEC |
| Mar 5, 2025 | Maraoui Claude | CEO | Sell | 28,901 | $5.04 | $146K | SEC |
| Feb 24, 2025 | Benesch Joseph | CFO | Sell | 1,365 | $5.19 | $7K | SEC |
| Aug 1, 2024 | Benesch Joseph | CFO | Sell | 9,324 | $5.47 | $51K | SEC |
| Jul 23, 2024 | Benesch Joseph | CFO | Sell | 4,055 | $5.40 | $22K | SEC |
| Mar 27, 2024 | ROSENWALD LINDSAY A MD | Director | Buy | 10,000 | $3.04 | $30K | SEC |
| Mar 25, 2024 | Maraoui Claude | CEO | Buy | 10,000 | $3.48 | $35K | SEC |
| Mar 25, 2024 | Smith Justin Adam | Director | Buy | 30,000 | $3.47 | $104K | SEC |
There were no open-market insider trades in DERM in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
71 investment managers reported holding DERM in SEC Form 13F filings for Q2 2026.
No congressional trades in DERM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).